Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs
Data up to Jan 2025
Total Citations Per Year
Abstract
References (61)
Staging of brain pathology related to sporadic Parkinson’s disease
2002 • 9,557 citations
Diagnosis and management of dementia with Lewy bodies
2005 • 4,771 citations
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
1991 • 4,669 citations
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
1996 • 3,940 citations
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
2006 • 2,656 citations
Neurodegenerative Tauopathies
2001 • 2,276 citations
The Lewy body variant of Alzheimer's disease
1990 • 1,057 citations
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
2003 • 830 citations
Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry
2000 • 686 citations
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
2002 • 666 citations
Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
2002 • 650 citations
Aging and Extrapyramidal Function
1977 • 650 citations
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
1996 • 641 citations
Neuropathology of Cognitively Normal Elderly
2003 • 630 citations
Accumulation of Phosphorylated α-Synuclein in Aging Human Brain
2003 • 342 citations
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
2004 • 291 citations
Interface between tauopathies and synucleinopathies: A tale of two proteins
2006 • 258 citations
Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients
1987 • 254 citations
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
2004 • 248 citations
Lewy body-related ?-synucleinopathy in the aged human brain
2004 • 245 citations
Motor signs during the course of Alzheimer disease
2004 • 239 citations
Lewy Body-Related α-Synucleinopathy in Aging
2004 • 187 citations
Pathology associated with sporadic Parkinson’s disease — where does it end?
2006 • 179 citations
More than just two peas in a pod: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases
2004 • 177 citations
Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation
2004 • 171 citations
The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
2005 • 165 citations
Fibrillization of ?-synuclein and tau in familial Parkinson's disease caused by the A53T ?-synuclein mutation
2004 • 164 citations
Substantia nigra tangles are related to gait impairment in older persons
2005 • 162 citations
Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)
2005 • 148 citations
Progression of gait disorder and rigidity and risk of death in older persons
2002 • 147 citations
Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia)
1998 • 147 citations
Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
2006 • 146 citations
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease
1989 • 138 citations
Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study
2003 • 129 citations
Pathological correlates of extrapyramidal signs in Alzheimer's disease
1997 • 127 citations
Parkinsonianlike Signs and Risk of Incident Alzheimer Disease in Older Persons
2003 • 122 citations
Subtle extrapyramidal signs can predict the development of dementia in elderly individuals
1993 • 120 citations
Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study
2003 • 116 citations
Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study
2003 • 115 citations
Lewy Bodies in the Amygdala
2004 • 114 citations
The impact of cerebrovascular lesions in Alzheimer disease
2003 • 99 citations
Extrapyramidal Motor Signs in Clinically Diagnosed Alzheimer Disease
1996 • 86 citations
Understanding the pathology of vascular cognitive impairment
2004 • 85 citations
Parkinsonian Signs in Older People in a Community-Based Study
2004 • 78 citations
Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism
2006 • 72 citations
Dementia with Lewy bodies from the perspective of tauopathy
2003 • 69 citations
Progression of Parkinsonism and Loss of Cognitive Function in Alzheimer Disease
2000 • 56 citations
Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease
2002 • 54 citations
Characteristics of alpha-synucleinopathy in centenarians
2006 • 49 citations
Substantia Nigra Lesions in Alzheimer Disease and Normal Aging
1995 • 46 citations
The role of α-synuclein and tau in neurodegenerative movement disorders
2005 • 41 citations
Pathology and pathophysiology of vascular cognitive impairment. A critical update.
2004 • 34 citations
Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
1989 • 33 citations
Sporadic tauopathies: Pick's disease, corticobasal degeneration, progressive supranuclear palsy and argyrophilic grain disease
2004 • 28 citations
Decreased nigral neuromelanin in Alzheimer's disease
2003 • 21 citations
Age-Related Changes in the Neurologic Examination of Healthy Sexagenarians, Octogenarians, and Centenarians
1994 • 16 citations
Clinical parkinsonism in dementia patients with substantia nigra Lewy bodies
1999 • 10 citations
Recent Progress in Alzheimer's and Parkinson's Diseases
2005 • 7 citations
Inconsistency between severe substantia nigra degeneration with Lewy bodies and clinical parkinsonism in dementia patients: a cliniconeuropathological study
2000 • 6 citations
Neuropathology and tau
2005 • 2 citations
Alzheimer’s disease: a true tauopathy fueled by amyloid precursor protein dysfunction A Delacourte
2005 • 2 citations